PET Coverage-With-Evidence Debate Continues: AHIP Urges Restraint
This article was originally published in The Gray Sheet
Executive Summary
Private insurers say data collected in a registry of Medicare cancer patients that have undergone positron emission tomography imaging does not support broader coverage of FDG-PET oncology applications